Epsilon M&A Deal Report - Biotrin Group
Transaction Multiples for the Valuation of Private Companies
Diasorin / Biotrin Group
No EMAT :
19236
Announced Date :
09/07/2008
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Diasorin
Target :
Biotrin Group
Country :
Ireland
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Medical Diagnostic Laboratory
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Laboratory Testing Services
Business Description :
Biotrin Group, a diagnostics company, engages in the research, development, manufacturing, and marketing of tests for the clinician and research scientists . > Operates in 2 divisions: Infectious...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|||
| Current |
|
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Diagnostic Laboratory » = 55
- Number of EMAT Reports / sub-sector « Laboratory Testing Services » = 36
| Date | Acquirer | Target | Country | Multiples | See details |
| 14/08/2008 | Nanogen | Elitech Group | France | ** | 19216 |
| 27/04/2007 | Private group led by management of Penn Pharmaceutical Services Ltd | Penn Pharmaceuticals | Wales | ** | 19179 |
Source: Epsilon Research / EMAT
